| Clinical data | |
|---|---|
| Other names | β-MeO-MDPEA; β-Methoxy-MDPEA; 3,4-Methylenedioxy-β-methoxyphenethylamine |
| MedlinePlus | a609035 |
| Routes of administration | Oral[1] |
| Drug class | Psychoactive drug |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 6–8 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C10H13NO3 |
| Molar mass | 195.218 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
BOH, also known as3,4-methylenedioxy-β-methoxyphenethylamine or asβ-methoxy-MDPEA, is adrug of thephenethylamine,MDxx, andBOx families.[1] It is the β-methoxyanalogue of3,4-methylenedioxyphenethylamine (MDPEA) and is also more distantly related tomethylone (β-keto-MDMA).[1]
In his bookPiHKAL (Phenethylamines I Have Known and Loved),Alexander Shulgin lists BOH's dose range as 80 to 120 mgorally and itsduration as 6 to 8 hours.[1] The effects of BOH were reported to include distinct body awareness, a faint sense of innerwarmth, mildmood enhancement,pupil dilation, skin prickling, bodily discomfort,loose bowels,decreased appetite,thirstiness, vaguenausea, andcold feet.[1] There were no clearpsychedelic,entactogenic, oreuphoriant effects described.[1]
On account of itsstructural similarity tonorepinephrine, BOH might be purelyadrenergic in nature.[1]
Thechemical synthesis of BOH has been described.[1]
Analogues of BOH include3,4-methylenedioxyphenethylamine (MDPEA; homopiperonylamine),3C-BOH (α-methyl-BOH),BOB (β-methoxy-2C-B),BOD (β-methoxy-2C-D), andmethylone (β-keto-MDMA), among others.[1]
BOH was first described in thescientific literature byAlexander Shulgin,Peyton Jacob III, andDarrell Lemaire in 1985.[2] Subsequently, it was described in greater detail by Shulgin in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1]
This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[3]